broadly neutralizing antibodies (Weill Cornell Medical College/Rockefeller University/California Institute of Technology/The Scripps Research Institute/Mayo Clinic/New York University School of Medicine/Ragon Institute)

N/A

Report date: 2025/06/11 10:16:54

Base Information

Drug Namebroadly neutralizing antibodies (Weill Cornell Medical College/Rockefeller University/California Institute of Technology/The Scripps Research Institute/Mayo Clinic/New York University School of Medicine/Ragon Institute)
Drug Alias NameAR-3BAR-3AAR-4A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A